Skip to content
HowShorted

Acorda Therapeutics, Inc. short interest in 2019

In 2019, Acorda Therapeutics, Inc.'s disclosed short interest ran from 21.03% of shares outstanding on 15 Jan 2019 to 28.61% on 31 Dec 2019, a change of +7.58 percentage points. The year's high was 33.04% on 30 Aug 2019 and its low 21.03% on 15 Jan 2019, averaging 26.00% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.46 days on 15 Jul 2019. Full history: Acorda Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Acorda Therapeutics, Inc. in 2019

2019 in figures

Start of year
21.03% (15 Jan 2019)
End of year
28.61% (31 Dec 2019)
Change
+7.58 pp
High
33.04% (30 Aug 2019)
Low
21.03% (15 Jan 2019)
Average
26.00%
Highest days to cover
19.46 (15 Jul 2019)
SEC filings marked
10

Every report in 2019

Acorda Therapeutics, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201921.03%9.16results (8-K)
31 Jan 201921.83%13.46
15 Feb 201923.99%13.86results (8-K)
28 Feb 201922.42%7.6510-K filed
15 Mar 201923.05%12.88
29 Mar 201921.78%16.26
15 Apr 201923.65%17.44
30 Apr 201924.24%13.95
15 May 201926.06%11.83results (8-K), 10-Q filed
31 May 201926.11%16.91
14 Jun 201922.85%9.82
28 Jun 201928.00%12.99
15 Jul 201928.78%19.46
31 Jul 201929.43%16.88
15 Aug 201932.27%5.73results (8-K), 10-Q filed
30 Aug 201933.04%8.54
13 Sep 201928.12%6.89
30 Sep 201926.73%7.25
15 Oct 201929.47%11.23
31 Oct 201929.44%8.94results (8-K)
15 Nov 201922.31%4.84results (8-K), 10-Q filed
29 Nov 201924.47%9.84
13 Dec 201926.32%8.68
31 Dec 201928.61%4.19

See also: Acorda Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.